Warberg Asset Management’s Zura Bio Limited Warrants ZURAW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-12,909
Closed -$5.16K 258
2024
Q2
$5.16K Sell
12,909
-12,909
-50% -$6.55K ﹤0.01% 189
2024
Q1
$6.58K Hold
25,818
﹤0.01% 175
2023
Q4
$4.39K Hold
25,818
﹤0.01% 195
2023
Q3
$8.78K Hold
25,818
﹤0.01% 180
2023
Q2
$9.04K Buy
+25,818
New +$9.11K ﹤0.01% 182

Warberg Asset Management's ZURAW Position: Q3 2024 in Review

Warberg Asset Management sold out of Zura Bio Limited Warrants (ZURAW) in Q3 2024, closing a stake of 12,909 shares — an estimated $5.16K sold.

Warberg Asset Management first reported a position in ZURAW in Q2 2023 and held it in 5 quarters. The position peaked at $9.04K in Q2 2023. 0 funds tracked by Wall St. Rank hold ZURAW as of Q3 2024.

  • Warberg Asset Management reported no remaining Zura Bio Limited Warrants position as of Q3 2024 after selling out during the quarter.
  • Warberg Asset Management sold 12,909 Zura Bio Limited Warrants shares in Q3 2024, an estimated $5.16K.
  • Warberg Asset Management first reported a position in Zura Bio Limited Warrants in Q2 2023 and held it in 5 quarters.
  • Warberg Asset Management's Zura Bio Limited Warrants position peaked at $9.04K in Q2 2023.
  • 0 funds tracked by Wall St. Rank held Zura Bio Limited Warrants as of Q3 2024.

Based on Warberg Asset Management's 13F filing for Q3 2024, filed 6 Nov 2024.